Cureatr expands board of directors with new addition

Cureatr, a mobile care coordination solution for healthcare providers, has added Carl Byers to its board of directors. The appointment is effective immediately. Byers is a venture partner at Fidelity Biosciences, a VC fund. Cureatr's backers include Cardinal Partners, Milestone Venture Partners, JMI Services and the Partnership Fund for New York City.

10 April 2014•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail